Published: Guidance, quality standards and advice

Skip to filtersSkip to results

Skip to results

Keyword or reference number

Keyword or reference number

Last updated date

Last updated date

Area of interest

Area of interest

Type 1 selected

Type

Guidance programme

Showing 1051 to 1100 of 2013

TitleReference numberPublishedLast updated
Selective internal radiation therapy for unresectable primary intrahepatic cholangiocarcinomaHTG489
Eltrombopag for treating chronic immune thrombocytopeniaTA293
Romiplostim for the treatment of chronic immune thrombocytopeniaTA221
Myeloma: diagnosis and managementNG35
Lyme diseaseNG95
Dabrafenib with trametinib for adjuvant treatment of resected BRAF V600 mutation-positive melanomaTA544
Renal replacement therapy and conservative managementNG107
Decision-making and mental capacityNG108
Cabozantinib for untreated advanced renal cell carcinomaTA542
Tofacitinib for treating active psoriatic arthritis after inadequate response to DMARDsTA543
E‑vita open plus for treating complex aneurysms and dissections of the thoracic aortaHTG326
Inotuzumab ozogamicin for treating relapsed or refractory B-cell acute lymphoblastic leukaemiaTA541
Intravesical microwave hyperthermia and chemotherapy for non-muscle-invasive bladder cancerHTG487
Preventing suicide in community and custodial settingsNG105
Lutetium (177Lu) oxodotreotide for treating unresectable or metastatic neuroendocrine tumoursTA539
Leadless cardiac pacemaker implantation for bradyarrhythmiasHTG484
Superior rectal artery embolisation for haemorrhoidsHTG485
Flu vaccination: increasing uptakeNG103
Dinutuximab beta for treating neuroblastomaTA538
Sutureless aortic valve replacement for aortic stenosisHTG483
Transurethral water vapour ablation for lower urinary tract symptoms caused by benign prostatic hyperplasiaHTG482
Lenvatinib and sorafenib for treating differentiated thyroid cancer after radioactive iodineTA535
Alectinib for untreated ALK-positive advanced non-small-cell lung cancerTA536
Ixekizumab for treating active psoriatic arthritis after inadequate response to DMARDsTA537
Community pharmacies: promoting health and wellbeingNG102
Dupilumab for treating moderate to severe atopic dermatitisTA534
Low-intensity pulsed ultrasound to promote healing of fresh fractures at low risk of non-healingHTG479
Low-intensity pulsed ultrasound to promote healing of fresh fractures at high risk of non-healingHTG480
Low-intensity pulsed ultrasound to promote healing of delayed-union and non-union fracturesHTG481
Ocrelizumab for treating relapsing–remitting multiple sclerosisTA533
Superior capsular augmentation for massive rotator cuff tearsHTG477
Transaxial interbody lumbosacral fusion for severe chronic low back painHTG478
Pembrolizumab for untreated PD-L1-positive metastatic non-small-cell lung cancerTA531
Biomarker tests to help diagnose preterm labour in women with intact membranesHTG476
Nivolumab for treating locally advanced unresectable or metastatic urothelial cancer after platinum-containing chemotherapyTA530
Beta interferons and glatiramer acetate for treating multiple sclerosisTA527
Dementia: assessment, management and support for people living with dementia and their carersNG97
Donepezil, galantamine, rivastigmine and memantine for the treatment of Alzheimer's diseaseTA217
Unilateral MRI-guided focused ultrasound thalamotomy for treatment-resistant essential tremorHTG474
Laparoscopic ventral mesh rectopexy for internal rectal prolapseHTG475
Arsenic trioxide for treating acute promyelocytic leukaemiaTA526
Guselkumab for treating moderate to severe plaque psoriasisTA521
Midostaurin for untreated acute myeloid leukaemiaTA523
Brentuximab vedotin for treating CD30-positive Hodgkin lymphomaTA524
Atezolizumab for treating locally advanced or metastatic urothelial carcinoma after platinum-containing chemotherapyTA525
Intranasal phototherapy for allergic rhinitisHTG473
Cancer of the upper aerodigestive tract: assessment and management in people aged 16 or overNG36
Low-level laser therapy for preventing or treating oral mucositis caused by radiotherapy or chemotherapyHTG472
Atezolizumab for treating locally advanced or metastatic non-small-cell lung cancer after chemotherapyTA520
Percutaneous balloon valvuloplasty for fetal critical aortic stenosisHTG471

Results per page

  1. 10
  2. 25
  3. 50
  4. All